CCM
OFIX icon

Channing Capital Management’s Orthofix Medical OFIX Stock Holding History

Channing Capital Management’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20,142
Closed -$259K – 149
2023
Q3 		$259K Hold
20,142
– – 0.01% 138
2023
Q2 		$364K Buy
+20,142
New +$376K 0.01% 124

Other funds holding OFIX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ECM
Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Channing Capital Management's OFIX Position: Q4 2023 in Review

Channing Capital Management sold out of Orthofix Medical (OFIX) in Q4 2023, closing a stake of 20,142 shares — an estimated $259K sold.

Channing Capital Management first reported a position in OFIX in Q2 2023 and held it in 2 quarters. The position peaked at $364K in Q2 2023. 156 funds tracked by Wall St. Rank hold OFIX as of Q4 2023.

  • Channing Capital Management reported no remaining Orthofix Medical position as of Q4 2023 after selling out during the quarter.
  • Channing Capital Management sold 20,142 Orthofix Medical shares in Q4 2023, an estimated $259K.
  • Channing Capital Management first reported a position in Orthofix Medical in Q2 2023 and held it in 2 quarters.
  • Channing Capital Management's Orthofix Medical position peaked at $364K in Q2 2023.
  • 156 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2023.

Based on Channing Capital Management's 13F filing for Q4 2023, filed 6 Feb 2024.